Postoperative Cognitive Dysfunction Recruiting Phase 4 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0036861 (Postoperative Cognitive Dysfunction)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03639896Endothelial Injury Mechanism in Elderly Patients Undergoing Major SurgeryTreatment
NCT03480061Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac SurgeryPrevention